Table 2.
Prevalence of metabolic diseases and metabolic variables among PLIN1 autoantibody–positive and –negative patients with AGL
| Positive | Negative | P | |
|---|---|---|---|
| N | 17 | 29 | |
| Diabetes | 71 | 52 | 0.24 |
| Hypertriglyceridemia | 80 | 75 | 1.0 |
| Hypertension | 12 | 39 | 0.09 |
| Acute pancreatitis | 12 | 14 | 1.0 |
| Serum glucose (mg/dL) | 88 (62–332) | 103 (59–316) | 0.62 |
| Serum triglycerides (mg/dL) | 343 (64–2,693) | 278 (116–5,436) | 0.68 |
| Serum HDL cholesterol (mg/dL) | 23 (11–51) | 30 (10–87) | 0.16 |
| Blood HbA1c (%) | 7.2 (5–13) | 5.1 (4.5–10.3) | 0.051 |
Data are percentages or median (minimum–maximum) unless otherwise indicated.